Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-06

Clinical Trial Results: Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and tolerability of metformin in people with tuberculosis and HIV coinfection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Tuberculosis, Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2026-08-06